BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32141702)

  • 21. The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism.
    Zhu H; Xiao Y; Guo H; Guo Y; Huang Y; Shan Y; Bai Y; Lin X; Lu H
    Aging (Albany NY); 2021 Dec; 13(23):25089-25105. PubMed ID: 34863080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.
    Xie F; Huang M; Lin X; Liu C; Liu Z; Meng F; Wang C; Huang Q
    Sci Rep; 2018 May; 8(1):8102. PubMed ID: 29802402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
    Chen Q; Wang P; Fu Y; Liu X; Xu W; Wei J; Gao W; Jiang K; Wu J; Miao Y
    Oncol Rep; 2017 Dec; 38(6):3567-3573. PubMed ID: 29039566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.
    Chen X; Bui KC; Barat S; Thi Nguyen ML; Bozko P; Sipos B; Kalesse M; Malek NP; Plentz RR
    Cancer Lett; 2017 Jul; 399():20-28. PubMed ID: 28408354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
    Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
    BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT.
    Zhu F; Dai SN; Xu DL; Hou CQ; Liu TT; Chen QY; Wu JL; Miao Y
    Biomed Pharmacother; 2020 May; 125():109972. PubMed ID: 32036221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
    Oria VO; Lopatta P; Schmitz T; Preca BT; Nyström A; Conrad C; Bartsch JW; Kulemann B; Hoeppner J; Maurer J; Bronsert P; Schilling O
    Mol Oncol; 2019 Feb; 13(2):456-479. PubMed ID: 30556643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis.
    Chen L; Xu X; Wen X; Xu S; Wang L; Lu W; Jiang M; Huang J; Yang D; Wang J; Zheng M; Zhou XZ; Lu KP; Liu H
    Cancer Sci; 2019 Aug; 110(8):2442-2455. PubMed ID: 31148345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.
    Zhou L; Jiao X; Peng X; Yao X; Liu L; Zhang L
    J Cell Physiol; 2020 Nov; 235(11):8141-8154. PubMed ID: 31957029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.
    Momeny M; Esmaeili F; Hamzehlou S; Yousefi H; Javadikooshesh S; Vahdatirad V; Alishahi Z; Mousavipak SH; Bashash D; Dehpour AR; Tavangar SM; Tavakkoly-Bazzaz J; Haddad P; Kordbacheh F; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Cell Oncol (Dordr); 2019 Aug; 42(4):491-504. PubMed ID: 31025257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer.
    Jagadeeshan S; Subramanian A; Tentu S; Beesetti S; Singhal M; Raghavan S; Surabhi RP; Mavuluri J; Bhoopalan H; Biswal J; Pitani RS; Chidambaram S; Sundaram S; Malathi R; Jeyaraman J; Nair AS; Venkatraman G; Rayala SK
    Ann Oncol; 2016 Aug; 27(8):1546-56. PubMed ID: 27117533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
    Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
    J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine.
    Li H; Zhou W; Li L; Wu J; Liu X; Zhao L; Jia L; Sun Y
    Neoplasia; 2017 Jun; 19(6):509-518. PubMed ID: 28535453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
    Liu QH; Shi ML; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.